Update July 12 - July 18, 2021, Dr. Peter J. Lansberg MD, PhD Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics COVID-19 publications - Week 28 2021 1059 Publications PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected] Reliable on-line resources for Covid 19 WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap) Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database COVID-19 prevention network Covid-Plex trial - (plasma exchange & convalescent plasma trial) Mainstream Media New York Times - Corona update The Delta Variant Is the Symptom of a Bigger Threat: Vaccine Refusal No Longer ‘Hidden Victims,’ Children Are Dying as Virus Surges in Indonesia The Most Influential Spreader of Coronavirus Misinformation Online Israeli Data Suggests Possible Waning in Effectiveness of Pfizer Vaccine Persuasion vs. Coercion: Vaccine Debate in Europe Heats Up The bubble bursts: New Zealand suspends quarantine-free travel from Australia. Should Vaccinated People Start Wearing Masks Again? Why Vaccinated People Are Getting ‘Breakthrough’ Infections Washington Post - Corona update If you got the J&J vaccine, should you get a booster dose of Pfizer or Moderna? More than 4 million dead: Tracking global cases Europe’s hotels and restaurants are eager to welcome tourists — if they can find enough staff Health experts discuss vaccines Why some experts recommend upgrading to N95 masks to help fight the delta variant Guardian - Corona update Indonesia loosens Covid restrictions despite record deaths Doctors warn over increasing number of young people with Covid in ICU Under-30s reluctant to take Covid vaccine cite fertility and side-effect concerns ‘Heart-wrenching’: inside a hospital grappling with Delta and vaccine hesitancy PHE upgrade Delta variant’s risk level due to reinfection risk Key Articles 1. Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know? J. Clin. Med. Res. 2021; 13:317-325Vasireddy D, Vanaparthy R, Mohan G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267839 2. The devil in the details: Herd immunity and pandemic response. Cell Host Microbe 2021; 29:1048-1051Schaeffer B, Taylor B, Bushman M, Hanage WP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265244 3. The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis. Int. J. Immunopathol. Pharmacol. 2021; 35:20587384211031763Golpour M, Mousavi T, Alimohammadi M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250834 4. Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2021; 8:ofab284Yetmar ZA, Chesdachai S, Kashour T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258316 5. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc. Toxicol. 2021:1-9Vitiello A, Ferrara F. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255300 6. Venous and arterial thromboembolic disease in COVID-19. J. Thromb. Thrombolysis 2021:1-3Ten Berg J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255267 7. Outcome and death risk of diabetes patients with Covid-19 receiving pre- hospital and in-hospital metformin therapies. Diabetol. Metab. Syndr. 2021; 13:76Tamura RE, Said SM, de Freitas LM, Rubio IGS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256824 8. A living mapping review for COVID-19 funded research projects: nine- month update. Wellcome Open Res 2020; 5:209Norton A, Bucher A, Antonio E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33117894 9. Self-infection with speech aerosol may contribute to COVID-19 severity. J Intern Med 2021; Kushalnagar P, Chow CC, Bax A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268819 10. Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review. BMJ Open 2021; 11:e050519Jenniskens K, Bootsma MCJ, Damen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253676 11. Recurrent massive pulmonary embolism following catheter directed thrombolysis in a 21-year-old with COVID-19: a case report. Eur Heart J Case Rep 2021; 5:ytab140Hirschbaum JH, Bradley CP, Kingsford P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268475 12. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021; 45:123Hembram P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257504 13. Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies. Acta Cardiol Sin 2021; 37:355-364Chen PW, Tsai ZY, Chao TH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257485 14. COVID-19 and cardiovascular system-a comprehensive review. Rev Cardiovasc Med 2021; 22:343-351AlShahrani I, Hosmani J, Shankar VG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258902 15. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021:1410768211032850Aiyegbusi OL, Hughes SE, Turner G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265229 Basic Science (32 articles) 1. Recent advances in developing small-molecule inhibitors against SARS-CoV- 2. Acta Pharm Sin B 2021; Xiang R, Yu Z, Wang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249607 2. Transmission trend of the COVID-19 pandemic predicted by dendritic neural regression. Appl Soft Comput 2021; 111:107683Dong M, Tang C, Ji J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248448 3. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis. Brief. Bioinform. 2021; Rahman MR, Islam T, Shahjaman M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260684 4. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021; 45:123Hembram P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257504 5. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell 2021; Nathan A, Rossin EJ, Kaseke C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265281 6. Metal Organic Frameworks as Biosensing Materials for COVID-19. Cell. Mol. Bioeng. 2021:1-19Udourioh GA, Solomon MM, Epelle EI. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249167 7. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. Cell Rep. 2021:109414Neidleman J, Luo X, George AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260965 8. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol 2021; 229:108795Jamaly S, Tsokos MG, Bhargava R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252574 9. COVID-19 candidate genes and pathways potentially share the association with lung cancer. Comb. Chem. High Throughput Screen. 2021; Alnajeebi AM, Alharbi HFH, Alelwani W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254909 10. Efficient machine learning model for predicting drug-target interactions with case study for Covid-19. Comput. Biol. Chem. 2021; 93:107536El-Behery H, Attia AF, El-Feshawy N, Torkey H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271420 11. Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape. Comput. Biol. Med. 2021; 135:104525Rampogu S, Gajula RG, Lee G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252682 12. The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology. Front Cell Dev Biol 2021; 9:684874Cui H, Su S, Cao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249938 13. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3- Chymotrypsin-Like Protease. Front Chem 2021; 9:692168Ferreira JC, Fadl S, Villanueva AJ, Rabeh WM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249864 14.